throbber
11718
`
`Langmuir 2007, 23, 11718-11725
`
`Cell and Protein Compatibility of Parylene-C Surfaces
`Tracy Y. Chang,†,# Vikramaditya G. Yadav,‡,¶,# Sarah De Leo,§ Agustin Mohedas,^
`Bimal Rajalingam,£ Chia-Ling Chen,| Selvapraba Selvarasah,| Mehmet R. Dokmeci,| and
`Ali Khademhosseini*,£,¶
`
`Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139,
`Department of Chemical Engineering, UniVersity of Waterloo, Waterloo, Canada N2L 3G1, Department of
`Biological Engineering, Louisiana State UniVersity, Baton Rouge, Louisiana 70808, Department of
`Biomedical Engineering, Texas A&M UniVersity, College Station, Texas 77843, Center for Biomedical
`Engineering, Department of Medicine, Brigham and Women’s Hospital, HarVard Medical School, Boston,
`Massachusetts 02139, Department of Electrical and Computer Engineering, Northeastern UniVersity,
`Boston, Massachusetts 02115, and HarVard-MIT DiVision of Health Sciences and Technology,
`Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
`ReceiVed June 11, 2007. In Final Form: August 9, 2007
`
`Parylene-C, which is traditionally used to coat implantable devices, has emerged as a promising material to generate
`miniaturized devices due to its unique mechanical properties and inertness. In this paper we compared the surface
`properties and cell and protein compatibility of parylene-C relative to other commonly used BioMEMS materials.
`We evaluated the surface hydrophobicity and roughness of parylene-C and compared these results to those of tissue
`culture-treated polystyrene, poly(dimethylsiloxane) (PDMS), and glass. We also treated parylene-C and PDMS with
`air plasma, and coated the surfaces with fibronectin to demonstrate that biochemical treatments modify the surface
`properties of parylene-C. Although plasma treatment caused both parylene-C and PDMS to become hydrophilic, only
`parylene-C substrates retained their hydrophilic properties over time. Furthermore, parylene-C substrates display a
`higher degree of nanoscale surface roughness (>20 nm) than the other substrates. We also examined the level of BSA
`and IgG protein adsorption on various surfaces and found that surface plasma treatment decreased the degree of protein
`adsorption on both PDMS and parylene-C substrates. After testing the degree of cell adhesion and spreading of two
`mammalian cell types, NIH-3T3 fibroblasts and AML-12 hepatocytes, we found that the adhesion of both cell types
`to surface-treated parylene-C variants were comparable to standard tissue culture substrates, such as polystyrene.
`Overall, these results indicate that parylene-C, along with its surface-treated variants, could potentially be a useful
`material for fabricating cell-based microdevices.
`
`1. Introduction
`Polymeric biomaterials are widely used in therapeutics1,2 and
`diagnostics3,4 as micro- and nanobiosensors for cell-based assays,
`drug delivery, and tissue-engineering applications.5 Polymeric
`microdevices are capable for analyzing cells and proteins,6-8
`
`* Corresponding author. E-mail: alik@mit.edu.
`† Department of Biology, Massachusetts Institute of Technology.
`‡ University of Waterloo.
`§ Louisiana State University.
`^ Texas A&M University.
`£ Harvard Medical School.
`| Northeastern University.
`¶ Harvard-MIT Division of Health Sciences and Technology, Mas-
`sachusetts Institute of Technology.
`# Denotes equal contributions.
`(1) Langer, R. Drug delivery. Drugs on target. Science 2001, 293 (5527),
`58-59.
`(2) Langer, R.; Vacanti, J. P. Tissue engineering. Science 1993, 260 (5110),
`920-926.
`(3) Bashir, R. BioMEMS: state-of-the-art in detection, opportunities and
`prospects. AdV. Drug DeliVery ReV. 2004, 56 (11), 1565-1586.
`(4) Byrne, M. E.; Park, K.; Peppas, N. A. Molecular imprinting within hydrogels.
`AdV. Drug DeliVery ReV. 2002, 54 (1), 149-161.
`(5) Khademhosseini, A.; Langer, R.; Borenstein, J.; Vacanti, J. P. Microscale
`technologies for tissue engineering and biology. Proc. Natl. Acad. Sci. U.S.A.
`2006, 103 (8), 2480-2487.
`(6) Folch, A.; Ayon, A.; Hurtado, O.; Schmidt, M. A.; Toner, M. Molding of
`deep polydimethylsiloxane microstructures for microfluidics and biological
`applications. J. Biomech. Eng. 1999, 121 (1), 28-34.
`(7) Khademhosseini, A.; Suh, K. Y.; Jon, S.; Eng, G.; Yeh, J.; Chen, G. J.;
`Langer, R. A soft lithographic approach to fabricate patterned microfluidic channels.
`Anal. Chem. 2004, 76 (13), 3675-3681.
`(8) Sia, S. K.; Whitesides, G. M. Microfluidic devices fabricated in poly-
`(dimethylsiloxane) for biological studies. Electrophoresis 2003, 24 (21), 3563-
`3576.
`
`generating tissue-engineering scaffolds,9-11 and miniaturizing
`bioassays for high-throughput experimentation.12 With the recent
`emergence of soft
`lithography, elastomers, such as poly-
`(dimethylsiloxane) (PDMS), have become enabling materials
`for the widespread fabrication and the use of microfabricated
`systems. PDMS offers numerous advantages over traditional
`biomaterials. It is relatively inexpensive, inert, nontoxic, and
`can be easily molded to form microstructures.13 Despite these
`desirable characteristics, PDMS has a number of shortcomings.
`For example, although PDMS has been shown to be compatible
`for short-term culturing of cells,14 little is known of its long-term
`stability in tissue-engineering applications and in vivo diagnostics.
`Therefore, it may be important to explore alternative biomaterials
`that can be used to fabricate biomedical microdevices. Poly-
`
`(9) Bianchi, F.; Vassalle, C.; Simonetti, M.; Vozzi, G.; Domenici, C.; Ahluwalia,
`A. Endothelial cell function on 2D and 3D micro-fabricated polymer scaffolds:
`applications in cardiovascular tissue engineering. J. Biomater. Sci., Polym. Ed.
`2006, 17 (1-2), 37-51.
`(10) Fidkowski, C.; Kaazempur-Mofrad, M. R.; Borenstein, J.; Vacanti, J. P.;
`Langer, R.; Wang, Y. Endothelialized microvasculature based on a biodegradable
`elastomer. Tissue Eng. 2005, 11 (1-2), 302-309.
`(11) Kaihara, S.; Borenstein, J.; Koka, R.; Lalan, S.; Ochoa, E. R.; Ravens,
`M.; Pien, H.; Cunningham, B.; Vacanti, J. P. Silicon micromachining to tissue
`engineer branched vascular channels for liver fabrication. Tissue Eng. 2000, 6
`(2), 105-117.
`(12) Thorsen, T.; Maerkl, S. J.; Quake, S. R. Microfluidic large-scale integration.
`Science 2002, 298 (5593), 580-584.
`(13) Whitesides, G. M.; Ostuni, E.; Takayama, S.; Jiang, X.; Ingber, D. E. Soft
`lithography in biology and biochemistry. Annu. ReV. Biomed. Eng. 2001, 3, 335-
`373.
`(14) Lee, J. N.; Jiang, X.; Ryan, D.; Whitesides, G. M. Compatibility of
`mammalian cells on surfaces of poly(dimethylsiloxane). Langmuir 2004, 20 (26),
`11684-11691.
`
`10.1021/la7017049 CCC: $37.00 © 2007 American Chemical Society
`Published on Web 10/04/2007
`
`Downloaded via COPYRIGHT CLEARANCE CTR DCMT DLVRY on September 16, 2020 at 15:25:26 (UTC).
`
`See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
`
`Novartis Exhibit 2030.001
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`Biocompatibility of Parylene-C
`
`Langmuir, Vol. 23, No. 23, 2007 11719
`
`(chloro-p-xylylene), also referred to as parylene-C, is one such
`potential candidate for fabricating biomedical devices.
`Parylene-C is a thermoplastic, crystalline, and transparent
`polymer that is extensively used as a coating for insulating
`implantable biomedical devices.15 In addition, parylene-C is
`chemically inert and nonbiodegradable. Parylene-C is synthesized
`from a low-molecular weight (MW) dimer, dichloro-di(p-
`xylylene), using a process that involves the decomposition of
`p-xylylene to yield chloro-p-xylylene, followed by the polym-
`erization of chloro-p-xylylene to parylene-C.16 Parylene-C can
`be vapor-deposited onto substrates to generate uniform, pinhole-
`free membranes that can be subsequently dry-etched using oxygen
`plasma to yield microscale features and patterns that are ideal
`for culturing cells.17 The all-carbon structural backbone, high-
`MW, and nonpolar entities make parylene-C highly resistant to
`most chemicals, as well as to fungal and bacterial growth. In
`addition to having conducive biochemical properties, parylene-C
`has a Young’s modulus of (cid:24)4 GPa18 (compared to 0.75 MPa for
`PDMS14)smaking it mechanically robust and highly suitable
`for fabricating stable and reusable microfluidic devices or
`stencils.17-22 Recent studies have shown parylene-C to be more
`hemocompatible and less thrombogenic than silicon.23 Parylene-C
`has also demonstrated high stability in vivo for a variety of
`applications, such as cardiovascular implants.24,25 Furthermore,
`parylene-C is a potentially useful material for in vitro cell culture
`studies. For example, we have developed the use of parylene-C
`stencils for patterning cells and proteins and for generation of
`cocultures with control over the degree of homotypic and
`heterotypic cell-cell interactions.26,27 Another recent study
`provides the methodology for making nanoscale sculptured thin
`films (STFs) out of parylene-C.28 Due to the high surface area
`to volume ratio of the STF, the parylene-C STF supports high
`level of cell adhesion.28 However, despite the apparent bio-
`compatibility of parylene-C, there has been no direct comparison
`of parylene-C to PDMS and other materials commonly used in
`BioMEMS.
`In this study, we compared the biocompatibility of parylene-C
`membranes with PDMS, glass, and optically clear virgin
`polystyrene by analyzing protein adsorption, cell adhesion, and
`cell morphology characteristics on each of these surfaces. In
`addition, we treated parylene-C and PDMS with air plasma and
`coated the surfaces of these substrates with fibronectin to study
`the effects of surface treatments on protein adsorption, cell
`
`(15) Loeb, G. E.; Walker, A. E.; Uematsu, S.; Konigsmark, B. W. Histological
`reaction to various conductive and dielectric films chronically implanted in the
`subdural space. J. Biomed. Mater. Res. 1977, 11 (2), 195-210.
`(16) Hahn, A. W.; Yasuda, H. K.; James, W. J.; Nichols, M. F.; Sadhir, R.
`K.; Sharma, A. K.; Pringle, O. A.; York, D. H.; Charlson, E. J. Glow discharge
`polymers as coatings for implanted devices. Biomed. Sci. Instrum. 1981, 17,
`109-113.
`(17) Tooker, A.; Meng, E.; Erickson, J.; Tai, Y. C.; Pine, J. Biocompatible
`parylene neurocages. Developing a robust method for live neural network studies.
`IEEE Eng. Med. Biol. Mag. 2005, 24 (6), 30-33.
`(18) Chen, P. J.; Shih, C. Y.; Tai, Y. C. Design, fabrication and characterization
`of monolithic embedded parylene microchannels in silicon substrate. Lab Chip
`2006, 6 (6), 803-810.
`(19) Licklider, L.; Wang, X. Q.; Desai, A.; Tai, Y. C.; Lee, T. D. A
`micromachined chip-based electrospray source for mass spectrometry. Anal. Chem.
`2000, 72 (2), 367-375.
`(20) Meng, E.; Wu, S.; Tai, Y. C. Silicon couplers for microfluidic applications.
`Fresenius’ J. Anal. Chem. 2001, 371 (2), 270-275.
`(21) Xie, J.; Miao, Y.; Shih, J.; Tai, Y. C.; Lee, T. D. Microfluidic platform
`for liquid chromatography-tandem mass spectrometry analyses of complex peptide
`mixtures. Anal. Chem. 2005, 77 (21), 6947-6953.
`(22) Xie, J.; Shih, J.; Lin, Q.; Yang, B.; Tai, Y. C. Surface micromachined
`electrostatically actuated micro peristaltic pump. Lab Chip 2004, 4 (5), 495-501.
`(23) Weisenberg, B. A.; Mooradian, D. L. Hemocompatibility of materials
`used in microelectromechanical systems: platelet adhesion and morphology in
`vitro. J. Biomed. Mater. Res. 2002, 60 (2), 283-291.
`(24) Schmidt, E. M.; McIntosh, J. S.; Bak, M. J. Long-term implants of
`parylene-C coated microelectrodes. Med. Biol. Eng. Comput. 1988, 26 (1), 96-
`101.
`
`adhesion, and spreading. Protein adsorption was studied using
`bovine serum albumin (BSA) and immunoglobulin G (IgG), and
`cell adhesion and spreading were studied using NIH-3T3
`fibroblast and AML-12 hepatocyte cell lines.
`
`2. Methods and Materials
`2.1. Fabrication of Parylene-C and PDMS. Three inch silicon
`wafers were first cleaned for (cid:24)10 min using a 1:1 piranha solution
`(equal volume mixture of H2SO4 and H2O2), sufficiently rinsed with
`deionized water, nitrogen-dried, and then coated with hexameth-
`yldisilazane (HMDS). Following pretreatment, the silicon wafers
`were deposited with dichloro-di(p-xylylene) by utilizing a Labcoater
`2 PDS 2010 chemical deposition system (Specialty Coating Systems,
`Indianapolis). Inside the deposition system, dichloro-di(p-xylylene)
`is first vaporized at 150 (cid:176)C and 1 torr and then pyrolyzed at 690 (cid:176)C
`and 0.5 torr to form chloro-p-xylylenesthe monomer of parylene-
`C. A reduction in the chamber temperature causes chloro-p-xylylene
`to condense onto the wafer surfaces to form parylene-C membranes.
`Initial loading of dichloro-di(p-xylylene) onto the silicon wafers
`determines the thickness of the parylene-C membrane at a rate of
`0.5 (cid:237)m/g. With the use of the aforementioned protocol, 10 (cid:237)m thick
`parylene-C membranes were fabricated on silicon substrates.
`The PDMS substrates were fabricated by directly curing a Sylgard
`184 (Essex Chemical) elastomer in the wells of a Costar 24-well
`TC-treated cell culture microplate for nearly 2 h at 70 (cid:176)C, using a
`10:1 weight ratio of elastomer to curing agent.
`2.2. Preparation of Surfaces. A total of eight types of surfaces
`were used in this study. Costar 24-well TC-treated cell culture
`microplates were utilized as optically clear virgin polystyrene
`substrates. Parylene-C experimental samples were prepared by
`carefully cutting the 10 (cid:237)m thick parylene-C membranes (section
`2.1) to form square-shaped pieces of (cid:24)5 mm(cid:2) 5 mm. Each cut-out
`piece of parylene-C was placed and sealed reversibly onto a PDMS-
`coated well in the microplate. Platinum glass coverslips, 18 mm (cid:2)
`18 mm in size, were used as the glass samples. Plasma-treated PDMS
`and parylene-C were obtained by treating the two polymers with air
`plasma in a Harrick PDC-001 plasma treatment chamber for 2 min.
`Protein coating to parylene-C and PDMS surfaces was performed
`by simply incubating a 5 (cid:237)g/mL fibronectin solution on the surfaces
`for 1 h.
`Each substrate was sterilized prior to the experiments. The
`sterilization of plain and plasma-treated surfaces consisted of UV
`irradiation for 30 s, followed by successive washes with 70% ethanol
`and sterile PBS, respectively. The sterilization of fibronectin-coated
`surfaces consisted of UV irradiation for 30 s followed by a 1 h
`incubation of a sterile solution of fibronectin (5 (cid:237)g/mL) on sterilized
`samples of plain PDMS and parylene-C.
`2.3. Surface Property Characterization. 2.3.1. Contact Angle
`Measurements. Contact angles were measured on static drops of
`water on different substrates by using a contact angle measurement
`system (Phoenix 300 plus, SEO) to provide information about
`hydrophobicity of the surfaces (See Table 1). The substrates were
`measured as-received or as-deposited (plain), and additional
`measurements were performed with a subset of these substrates
`(PDMS and parylene-C) that were treated with oxygen plasma and
`were coated with fibronectin. The contact angle measurements were
`
`(25) Eskin, S. G.; Armeniades, C. D.; Lie, J. T.; Trevino, L.; Kennedy, J. H.
`Growth of cultured calf aortic smooth muscle cells on cardiovascular prosthetic
`materials. J. Biomed. Mater. Res. 1976, 10 (1), 113-122.
`(26) Wright, D.; Rajalingam, B.; Karp, J.; Selvarasah, S.; Ling, Y.; Yeh, J.;
`Langer, R.; Dokmeci, M. R.; Khademhosseini, A. Reusable, reversibly sealable
`parylene membranes for cell and protein patterning. J. Biomed. Mater. Res. [Online
`early access]. DOI: 10.1002/jbm.a.31281. Published Online: Aug 29, 2007.
`http://www3.interscience.wiley.com/cgi-bin/fulltext/116310266/HTMLSTART.
`(27) Wright, D.; Rajalingam, B.; Selvarasah, S.; Dokmeci, M. R.; Khadem-
`hosseini, A. Generation of static and dynamic patterned co-cultures using
`microfabricated parylene-C stencils. Lab Chip [Online early access]. DOI: 10.1039/
`b706081e. Published Online: July 25, 2007. http://www.rsc.org/publishing/journals/
`LC/article.asp?doi)b706081e.
`(28) Demirel, M. C.; So, E.; Ritty, T. M.; Naidu, S. H.; Lakhtakia, A. Fibroblast
`cell attachment and growth on nanoengineered sculptured thin films. J. Biomed.
`Mater. Res., Part B 2007, 81 (1), 219-223.
`
`Novartis Exhibit 2030.002
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`11720 Langmuir, Vol. 23, No. 23, 2007
`
`Chang et al.
`
`substrates
`glass
`polystyrene
`PDMS
`
`parylene-C
`
`Table 1. Contact Angle Measurements
`contact angle (deg)
`plasma-treated
`fibronectin-coated
`
`untreated
`36.3 ( 2.6
`79.1 ( 5.9
`9.9 ( 1.1a
`105.9 ( 4.5
`99.0 ( 6.7
`73.7 ( 3.0b
`105.0 ( 10.4
`4.4 ( 2.4c
`97.2 ( 4.2
`a Measurements made immediately after PDMS was treated in oxygen
`plasma. b Measurements made after 40 min following treatment in oxygen
`plasma. c No significant change observed in measurements made
`immediately after and following 40 min after plasma treatment.
`
`Table 2. Surface Roughness Measurements
`substrate
`roughness (nm)
`1.6 ( 0.6
`1.2 ( 0.2
`19.3 ( 6.3
`19.3 ( 5.4
`29.0 ( 11.5
`2.2 ( 0.6
`0.4 ( 0.1
`3.2 ( 0.6
`
`glass
`polystyrene
`parylene-C
`plasma-treated parylene-C
`fibronectin-coated parylene-C
`PDMS
`plasma-treated PDMS
`fibronectin-coated PDMS
`
`performed by dispensing deionized water drops (5-10 (cid:237)L) on each
`substrate with a micropipette (Ted Pella Inc.). Each data point
`represents an average of >10 independent measurements.
`2.3.2. Surface Roughness Measurements. Surface roughness values
`of four different substrates (glass, polystyrene, PDMS, and parylene-
`C) as received were measured with atomic force microscopy (AFM)
`(Q-Scope 250, Quesant Instrument Corporation) using noncontact
`mode with a cantilever tip (NCS 16, Quesant). Scan areas of 50 (cid:237)m
`(cid:2) 50 (cid:237)m were randomly selected on the substrates. To obtain the
`surface roughness values from an as-deposited thin (10 (cid:237)m) parylene
`membrane, we first peeled the parylene off the silicon wafer and
`then placed it on top of a robust substrate (1 mm thick PDMS slab).
`Afterward, we performed the AFM measurements. To obtain the
`surface roughness of the surface-treated parylene-C, we applied
`surface treatments (O2 plasma treatment or fibronectin coating) on
`the parylene surface mounted on a PDMS slab and performed AFM
`surface roughness measurements. Three independent measurements
`from 5 (cid:237)m (cid:2) 5 (cid:237)m squares of each surface were performed and
`averaged. Roughness values (mean) acquired from various samples
`corresponding to the variations in surface heights are summarized
`in Table 2.
`2.4. Protein Adsorption Measurements. Protein adsorption was
`characterized by incubating 50 (cid:237)g/mL of fluorescein isothiocyanate
`(FITC)-conjugated BSA (Sigma-Aldrich) and 100 (cid:237)g/mL of FITC-
`conjugated IgG (Sigma-Aldrich) on each substrate for 1 h. The
`substrates were encased in aluminum foil to prevent photodegradation
`of the FITC. Following incubation, the substrates were rinsed with
`deionized water and imaged using a fluorescent microscope (Nikon
`TE 2000) with a constant exposure time of 500 ms. Emitted
`fluorescence was then measured using ImageJ pixel brightness
`analysis tool (National Institutes of Health, U.S.A.). The average
`pixel brightness of each image is an indirect measurement of the
`protein adsorption onto the substrates. Control substrates were also
`used to eliminate the effect of autofluorescence from the substrates.
`2.5. Cell Culture. NIH-3T3 fibroblasts were cultured in Dul-
`becco’s modification of Eagle medium (DMEM) (Invitrogen)
`supplemented with 10% fetal bovine serum (Atlanta Biologicals)
`and 1% penicillin-streptomycin (MediaTech). AML-12 hepatocytes
`were preserved in 44.5% DMEM and 44.5% Ham’s F12 media
`(Invitrogen) supplemented with 10% FBS and 1% penicillin-
`streptomycin (Sigma-Aldrich). The cells were maintained under
`humid conditions, at 37 (cid:176)C, and in a 5% CO 2 atmosphere.
`2.6. Preparation of Samples for Cell Adhesion. NIH-3T3
`fibroblasts and AML-12 hepatocytes were trypsinized and resus-
`pended in their respective media to form a 5 (cid:2) 104 cells/mL stock
`solution. A volume of 2 mL of this stock solution was then
`
`incubated on each of the substrates for 6 h. Each well of the Costar
`24-well microplate has a base area of 283.5 mm2. This corresponds
`to a loading density of (cid:24)353 cells/mm2. Next, the substrates were
`rinsed twice with 1(cid:2) phosphate-buffered saline (Invitrogen), and
`cells adhering to the substrates were then fixed using 4% parafor-
`maldehyde (Sigma-Aldrich) and permeabilized with 0.2% Triton
`X-100 (Sigma) for 10 and 5 min, respectively.
`2.7. Visualization and Imaging of Adhered Cells. To count the
`number of adhered cells on each surface, images of fluorescently
`labeled nuclei were collected using a fluorescent microscope (Nikon
`Eclipse TE 2000). Three pictures per well and three wells per substrate
`were analyzed and counted using ImageJ software.
`2.8. Visualization and Imaging of Cells for Estimating Shape
`Factors. To analyze cell spreading on various surfaces, data was
`collected from at least 70 adhered cells per sample. To effectively
`analyze cell shape, the dimensionless shape factor, S, was used to
`compare the spreading of cells. It is computed as
`
`S ) 4(cid:240)A/P2
`
`where A is the area occupied by the cell and P is the perimeter of
`the cell. A shape factor of 1 corresponds to a perfect circle, whereas
`a shape factor of 0 represents a line. Cell shape factors were computed
`utilizing the calibration and measurement features of the SPOT
`Imaging Software.
`
`3. Results and Discussion
`We evaluated the surface properties of parylene-C stencils in
`comparison with other commonly used biomedical materials,
`such as PDMS, glass, and polystyrene. In addition, we analyzed
`the effect of two common surface treatments, oxygen plasma
`and protein coating on these substrates. The surfaces were
`characterized for their hydrophobicity and roughness as well as
`for protein adsorption, cell adhesion, and cell morphology.
`Particular attention was paid to the differences between parylene-C
`and PDMS, due to their emerging applications in biomedical
`microfabrication.
`3.1. Surface Analysis. Surface hydrophobicity and surface
`roughness are important factors in cell adhesion and the resulting
`cellular morphology.14,29-31 In addition, hydrophobicity has also
`been shown to affect protein adsorption.32-35 Therefore, it is
`important to evaluate these properties in parylene-C membranes
`to understand the interaction of mammalian cells with these
`substrates. To assess the hydrophobicity of the surfaces, we
`measured contact angles of as-deposited and treated parylene-C
`surfaces and compared the values to control surfaces (Table 1).
`The substrates varied greatly in their water contact angles, from
`(cid:24)36(cid:176)
`for glass to (cid:24)111(cid:176)
`for PDMS. As-deposited parylene-C
`and plain PDMS were both hydrophobic as they exhibited contact
`angles of (cid:24)100(cid:176), which is consistent with our previous study. 36
`
`(29) MacDonald, D. E.; Rapuano, B. E.; Deo, N.; Stranick, M.; Somasundaran,
`P.; Boskey, A. L. Thermal and chemical modification of titanium-aluminum-
`vanadium implant materials: effects on surface properties, glycoprotein adsorption,
`and MG63 cell attachment. Biomaterials 2004, 25 (16), 3135-3146.
`(30) Miller, D. C.; Thapa, A.; Haberstroh, K. M.; Webster, T. J. Endothelial
`and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with
`nano-structured surface features. Biomaterials 2004, 25 (1), 53-61.
`(31) Lee, J. H.; Lee, H. B. A wettability gradient as a tool to study protein
`adsorption and cell adhesion on polymer surfaces. J. Biomater. Sci., Polym. Ed.
`1993, 4 (5), 467-481.
`(32) Toworfe, G. K.; Composto, R. J.; Adams, C. S.; Shapiro, I. M.; Ducheyne,
`P. Fibronectin adsorption on surface-activated poly(dimethylsiloxane) and its
`effect on cellular function. J. Biomed. Mater. Res., Part A 2004, 71 (3), 449-461.
`(33) Harnett, E. M.; Alderman, J.; Wood, T. The surface energy of various
`biomaterials coated with adhesion molecules used in cell culture. Colloids Surf.,
`B 2007, 55 (1), 90-97.
`(34) Warkentin, P.; Walivaara, B.; Lundstrom, I.; Tengvall, P. Differential
`surface binding of albumin, immunoglobulin G and fibrinogen. Biomaterials
`1994, 15 (10), 786-795.
`(35) Absolom, D. R.; Zingg, W.; Neumann, A. W. Protein adsorption to polymer
`particles: role of surface properties. J. Biomed. Mater. Res. 1987, 21 (2), 161-
`171.
`
`Novartis Exhibit 2030.003
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`Biocompatibility of Parylene-C
`
`Langmuir, Vol. 23, No. 23, 2007 11721
`
`Figure 1. Adsorption of FITC-BSA (A) and FITC-IgG (B) onto each of the substrates. (A) Adsorption of FITC-BSA onto parylene-C
`and PDMS exceeds that on glass and polystyrene. Surface modifications of parylene-C and PDMS show a negative effect on FITC-BSA
`adsorption. (B) FITC-IgG adsorbs onto glass, parylene-C, and PDMS in a comparable manner. Adsorption onto polystyrene is the highest.
`Surface modification of parylene-C and PDMS reduces their affinity for FITC-IgG. In general, plasma treatment and fibronectin coating
`the two polymers reduces their ability to adsorb proteins. The / indicates p < 0.05.
`
`Furthermore, fibronectin-coated parylene-C and PDMS were also
`hydrophobic (contact angles of (cid:24)100(cid:176)). This hydrophobic
`property of fibronectin-coated PDMS is confirmed by results
`obtained by other groups.32 Even though there has not been
`investigation in the past on fibronectin-coated parylene-C, it is
`logical to expect it to be hydrophobic. Because fibronectin
`coatings have no electron donor components and have low surface
`energy,33 materials coated with fibronectin would not form
`hydrogen bonds with water molecules, so they would become
`hydrophobic. Furthermore, air plasma treatment reduced the
`contact angle of both parylene-C and PDMS substrates to less
`
`(36) Selvarasah, S.; Chao, S. H.; Chen, C. L.; Mao, D.; Hopwood, J.; Ryley,
`S.; Sridhar, S.; Khademhosseini, A.; Busnaina, A.; Dokmeci, M. R. A high aspect
`ratio, flexible, transparent and low-cost parylene-C shadow mask technology for
`micro patterning applications. Presented at the 14th International Conference on
`Solid-State Sensors, Actuators and Microsystems, Lyon, France, June 10-14,
`2007; 533-536.
`
`than 10(cid:176). This finding agrees well with the previous findings that
`the formation of hydroxyl groups from the O2 plasma treatment
`process significantly increases the hydrophilicity of surfaces.8
`One of the main drawbacks of using PDMS for fluidic devices
`is that the plasma-induced hydrophilicity of the PDMS surfaces
`is short term.7 In many applications involving fluidics and cells,
`the ability to generate substrates that remain hydrophilic may be
`beneficial. To compare the stability of plasma-treated surfaces,
`we measured the contact angles of plasma-treated parylene-C
`and PDMS surfaces immediately and 40 min after plasma
`treatment. It was observed that although the plasma treatment
`initially decreased the contact angle values, the hydrophilicity
`of a PDMS substrate deteriorated rapidly (Table 1). This is due
`to the viscoelastic properties of PDMS, in which the surface
`molecules “turn over” with time exposing non-plasma-treated
`molecules of the PDMS on its surface. On the other hand, the
`
`Novartis Exhibit 2030.004
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`11722 Langmuir, Vol. 23, No. 23, 2007
`
`Chang et al.
`
`Figure 2. Adhesion of (A) NIH-3T3 fibroblasts and (B) AML-12 hepatocytes on the various substrates. (A) The cells do not adhere to
`as-deposited parylene-C and plain PDMS. Furthermore, plasma treatment and fibronectin coating of the two polymers increase their adhesiveness
`to NIH-3T3 cells. (B) Similar trends are exhibited by AML-12 adhesion to the various substrates. The / indicates p < 0.05.
`
`contact angle for plasma-treated parylene-C did not change
`significantly after 40 min. The fact that the plasma-treated parylene
`surface stays hydrophilic for longer periods could be advantageous
`for various biological applications. We next examined the surface
`roughness of the parylene-C and PDMS substrates by using AFM.
`As shown in Table 2, as-deposited and treated parylene-C
`substrates were significantly rougher compared to other substrates,
`including glass, PDMS, and polystyrene. Fibronectin-treated
`parylene-C surfaces had the highest roughness values of (cid:24)30
`nm. The higher surface roughness values of parylene-C may be
`due to the irregularities in the deposition process, which were
`further increased with fibronectin molecules adsorbed onto the
`surface. On the other hand, PDMS, glass, and polystyrene were
`much smoother with surface roughness values of <3 nm. An
`increase in surface roughness enhances the protein adsorption
`level, since there is more available surface area for proteins to
`attach.29 When there are more proteins adsorbed onto the surface,
`
`more integrin receptors on the cells will bind to the proteins and,
`therefore, mediate the attachment of cells.29
`
`3.2. Protein Adsorption. To generate substrates that are
`favorable for cell adhesion, a routine procedure is to coat a layer
`of adhesive proteins on the substrates. To measure protein
`adsorption properties of parylene-C relative to other substrates,
`we incubated each sample with fluorescently labeled BSA and
`IgG. First observation we made was that significantly more BSA
`and IgG adsorbed to polystyrene relative to glass. This finding
`is consistent with other studies that BSA and IgG adsorb more
`onto highly hydrophobic surfaces like polystyrene, compared to
`relatively hydrophilic surfaces like glass.14,29,31,33 Similarly, BSA
`adsorption level on plain PDMS and as-deposited parylene-C
`were 3 times higher relative to glass (Figure 1A). On the other
`hand, IgG adsorption levels on plain PDMS and as-deposited
`parylene-C were similar to adsorption on glass. We believe that
`
`Novartis Exhibit 2030.005
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`Biocompatibility of Parylene-C
`
`Langmuir, Vol. 23, No. 23, 2007 11723
`
`Figure 3. Dimensionless cell shape factor measurements for (A) NIH-3T3 fibroblasts and (B) AML-12 hepatocytes cultured on various
`substrates. (A) NIH-3T3 cells exhibit greater spreading on fibronectin-coated parylene-C and PDMS, as compared to the other substrates.
`(B) Due to nonaxial spreading, shape factor was not an adequate measurement of AML-12 proliferation on the surfaces, and ANOVA was
`not conducted on this data. The / indicates p < 0.05.
`
`this discrepancy is caused by the intrinsic difference in the
`structure of two proteins.
`In addition, we analyzed the effects of plasma treatment and
`initial protein coating on IgG and BSA adsorption. Plasma
`treatment is routinely used to increase the surface hydrophilicity
`of materials, such as PDMS and polystyrene, and can be used
`to modify the surface of parylene-C substrates (Table 1). In our
`studies, plasma treatment of parylene-C and PDMS increased
`the hydrophilicity of the surfaces and reduced the adhesion of
`both BSA (Figure 1A) and IgG (Figure 1B). This is because of
`increased hydrogen bonding between the surface and water
`molecules, which displaces the weak electrostatic interaction
`and hydrophobic interactions between serum proteins and the
`surface.33 In addition, fibronectin coatings, which improve cellular
`adhesion on biomaterials, could also be used to minimize the
`subsequent adsorption of BSA and IgG. This can be explained
`
`by the fact that the adsorption of the first layer of protein results
`in the creation of a thermodynamically stable interface of water
`molecules coupled with the hydrophilic regions of the adsorbed
`protein layer.34 This phenomenon is commonly used in immu-
`noassays, in which an adsorbed layer of protein is applied to
`minimize background adsorption of the antibody to the substrate.34
`Thus, our results indicate that as-deposited parylene-C has
`high BSA and IgG adsorption, while surface treatments on
`parylene-C can be used to decrease levels of adsorption of these
`proteins. The ability to modify the level of protein adsorption
`on the parylene-C substrates is of potential value for various
`biomedical applications and microfabrication techniques.
`3.3. Cell Adhesion and Spreading. To evaluate the cyto-
`compatibility of parylene-C substrates relative to other materials,
`we analyzed the adhesion of and spreading of fibroblast (NIH-
`3T3) and hepatocyte (AML-12) cell lines. In these experiments,
`
`Novartis Exhibit 2030.006
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`11724 Langmuir, Vol. 23, No. 23, 2007
`
`Chang et al.
`
`Figure 4. Micrographs of NIH-3T3 fibroblasts (A) and AML-12 hepatocytes (B) on various surfaces. The insets contain images which have
`been cropped and magnified for optimal viewing. Scale bar ) 100 (cid:237)m.
`
`cells were seeded on various surfaces and incubated for 6 h, and
`the adherent cells were counted and measur

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket